Wangzhi Li
Stock Analyst
(n/a)
# 4,492
Out of 4,497 analysts
5
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
4 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BGNE BeiGene | Upgrades: Buy | n/a | $154.74 | - | 2 | Dec 8, 2020 | |
| KRYS Krystal Biotech | Initiates: Buy | n/a | $203.66 | - | 1 | Oct 18, 2017 | |
| LPTX Leap Therapeutics | Initiates: Buy | n/a | $2.07 | - | 1 | Mar 7, 2017 | |
| CLRB Cellectar Biosciences | Initiates: Buy | n/a | $2.52 | - | 1 | Dec 21, 2016 |
BeiGene
Dec 8, 2020
Upgrades: Buy
Price Target: n/a
Current: $154.74
Upside: -
Krystal Biotech
Oct 18, 2017
Initiates: Buy
Price Target: n/a
Current: $203.66
Upside: -
Leap Therapeutics
Mar 7, 2017
Initiates: Buy
Price Target: n/a
Current: $2.07
Upside: -
Cellectar Biosciences
Dec 21, 2016
Initiates: Buy
Price Target: n/a
Current: $2.52
Upside: -